SOLENO THERAPEUTICS INC (SLNO)

US8342033094 - Common Stock

46.26  -0.54 (-1.15%)

After market: 46.26 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
41.38M24.40M31.53M36.29M23.49M
Research and Development
25.19M15.27M21.45M23.19M16.27M
Selling, General, and Administrative Expenses
13.48M9.84M10.81M8.76M6.93M
Operating Income
-41.38M-24.40M-31.53M-36.29M-23.49M
Interest Income/Expense
2.58M300.00K110.00K0.00-480.00K
Other Income/Expense
-182.00K30.00K510.00K11.65M-6.81M
Non Recurring Items
N/AN/AN/A-4.34M0.00
Income Before Taxes
-38.99M-24.07M-30.91M-24.64M-30.77M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-38.99M-24.07M-30.91M-24.64M-30.77M
EBITDA
-39.43M-22.44M-29.57M-34.34M-21.53M
 
Per Share Data
EPS Diluted Total Ops
-2.36-2.87-5.81-5.90-13.49
Non GAAP EPS
-2.97-3.32-5.85-6.60-12.90
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts